Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argent BioPharma Limited

0.073
0.000
Volume:18.34K
Turnover:1.34K
Market Cap:5.27M
PE:-0.16
High:0.073
Open:0.073
Low:0.073
Close:0.073
52wk High:0.570
52wk Low:0.070
Shares:72.18M
Float Shares:27.70M
Volume Ratio:0.22
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.445
EPS(LYR):-0.474
ROE:--
ROA:-121.60%
PB:-0.48
PE(LYR):-0.15

Loading ...

Argent BioPharma Says Case Study Confirms Treatment of Lennox-Gastaut Syndrome Patient with Cannabinoid-Based Formulation

MT Newswires Live
·
Aug 05

Argent BioPharma Starts Supply of Cannabinoid-Based Active Pharmaceutical Ingredient to Slovenian Hospital

MT Newswires Live
·
Jul 08

ASX ALERT-EU-GMP Cannabinoid API Supplied for Epilepsy in Slovenia-RGT.AX

Reuters
·
Jul 08

Notification regarding unquoted securities - RGT-RGT.AX

Reuters
·
Jul 02

Argent Biopharma Ltd. Unveils Presentation Highlighting Innovative CNS and Immune Disease Therapies

Reuters
·
Jun 10

Argent BioPharma Enters Germany - Europe's Largest Market

PR Newswire
·
Apr 24

Argent BioPharma Amends Convertible Note Terms with US-Based Search Fund; Shares Fall 6%

MT Newswires Live
·
Apr 23

Argent BioPharma to Collaborate With AusCann on Cannabinoid-Based Pharmaceutical Development

MT Newswires Live
·
Apr 15

BRIEF-Argent Biopharma And Auscann Enters Strategic Heads Of Agreement

Reuters
·
Apr 15

Argent BioPharma Signs Term Sheet with Medical Cannabis Research Company; Shares Down 5%

MT Newswires Live
·
Apr 10

BRIEF-Argent Biopharma Enters Collaboration Agreement For Argent EU GMP Facility In Malta

Reuters
·
Apr 09

ASX Runners of the Week: Whitehawk, OzAurum, Argent Biopharma & Galan

The West Australian
·
Apr 04

Argent BioPharma gains approval for prescription sales of CannEpil epilepsy treatment in Germany

Small Caps
·
Apr 03

BRIEF-Argent Biopharma Says Cannepil Receives Approval For Prescription In Germany

Reuters
·
Apr 03

ASX Small-Cap Stocks to Watch

MT Newswires Live
·
Apr 03

BRIEF-Argent BioPharma Reports Agreement For Malta Manufacturing Facility

Reuters
·
Mar 12

BRIEF-Argent BioPharma Posts HY Net Loss Attributable A$12.2 Million

Reuters
·
Feb 28

Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management

PR Newswire
·
Feb 13